Delivery Order SPE2DB24D2205-SPE2DB25FEFVD
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,728.00 to AmerisourceBergen Drug Corp for the supply of Testosterone 1% (25mg/2.5g) in 2.5-gram packages. The contract, awarded on August 15, 2025, with an ultimate completion date of August 18, 2025, represents a firm fixed-price delivery order with no set-aside designation. Performance will be conducted from the contractor's location in Conshohocken, Pennsylvania. This award is issued under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a delivery order valued at $1,372.98 to AmerisourceBergen Drug Corp for Testosterone 1% (25mg/2.5g) in 2.5-gram packages on July 22, 2025, with completion scheduled for July 23, 2025. This firm fixed-price delivery order, which utilizes no set-aside designation, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting federal medical supply requirements....
- The Defense Logistics Agency awarded a $2,592.00 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Testosterone 1% (25mg/2.5g) in 2.5-gram packages, with an ultimate completion date of July 28, 2025. This non-set-aside competitive award represents a routine pharmaceutical procurement through the federal medical supply chain. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for the Department of Defense and is...
- The Defense Logistics Agency awarded a $6,834.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Testosterone 1% (25mg/2.5g) in 2.5-gram packages. The contract, awarded on August 11, 2025, with an ultimate completion date of August 12, 2025, represents a competitive award with no set-aside designation. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Testosterone 50 mg/5 gram packets (unit dose, 5 grams) with a ceiling value of $1,010.68. This is a firm fixed price delivery order with no set-aside designation, utilizing competitive procurement procedures. The order is scheduled for ultimate completion by August 18, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a $1,296.00 delivery order to AmerisourceBergen Drug Corp for testosterone 1% (25 mg/2.5 g) in 2.5 gram packages under a firm fixed price contract. The order was awarded on August 5, 2025, with an ultimate completion date of August 6, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award represents a non-set-aside, competitively awarded delivery order with no small business or other...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Testosterone 1% (25mg/2.5g) in 2.5-gram packages, with a contract value of $1,645.21 and a completion date of August 13, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order valued at $1,723.61 to AmerisourceBergen Drug Corp for the supply of Testosterone Cypionate 200 mg/mL. This firm fixed-price, non-set-aside contract was awarded on July 21, 2025, with an ultimate completion date of July 22, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Testosterone 1% (50 mg/5 g) in unit dose packets of 5 grams. This competitively awarded, non-set-aside contract carries a ceiling value of $1,493.80 and represents a firm fixed-price delivery order with an ultimate completion date of August 5, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of the pharmaceutical distribution company AmerisourceBergen Corporation. The order is for the delivery of testosterone 1% (25mg/2.5g) pharmaceutical products, with a total ceiling value of $1,530.80 and a performance period through March 20, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA Troop Support...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEFVDDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Testosterone 1% (25mg/2.5g) in 2.5-gram packages, valued at $1,996.80. The award, issued on August 5, 2025, with an ultimate completion date of August 6, 2025, utilizes firm fixed-price pricing with no set-aside designation. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and running through December 2026. The parent IDC enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor that serves as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. As a competitively awarded contractor, the company demonstrates significant capability in fulfilling diverse federal medical supply requirements across multiple therapeutic domains. This delivery order for testosterone exemplifies the company's ongoing role in providing hormone treatments and specialized pharmaceutical products to support military healthcare operations globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 8/5/25 |